For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Trump’s State of the Union: A closer look at the claims
Last night, President Trump delivered a State of the Union address filled with optimism, applause lines, and bold claims about the country’s direction. There…
Citation
‘Just the beginning of enormous growth’: White House heralds strong jobs report
The Black Chronicle cited CEI’s expert on job growth in healthcare Senior Economist with the Competitive Enterprise Institute Ryan Young also interpreted the siloed…
Blog
FDA’s Moderna decision demonstrates how science and government are incompatible
Last week, the FDA announced that it would not be considering Moderna’s application for a new flu vaccine because the control group Moderna used…
Search Posts
News Release
Judge Rules Illumina-Grail Merger is Legal Despite FTC Antitrust Accusations
In a decision reached today, an administrative judge ruled that a proposed merger between Illumnia and Grail can proceed after ruling against a move…
City Journal
A Pox By Any Other Name
Anyone wondering why medical authorities seem so ineffectual need look no further than their newfound obsession with renaming the monkeypox virus and the disease it…
National Review
Monkeypox Outbreak Leveling Off, No Thanks to Government
Something that apparently surprised government bureaucrats and left-wing commentators but is, in fact, completely predictable is happening: The growth in new monkeypox cases is leveling off…
The New York Post
Key to CDC reform is undoing mission creep — and tossing woke programs
Centers for Disease Control and Prevention Director Rochelle Walensky has finally admitted what has been obvious to most observers for 2½ years: The agency has been…
C-SPAN
Video: Senior Fellow Joel Zinberg Joins C-SPAN to Discuss Senate Democratic Health Care and Prescription Drug Proposals
Senior Fellow Joel Zinberg joined the Washington Journal to discuss Senate Democratic Health Care and Prescription Drug Proposals. Click here to read more.
City Journal
No More Masks
Covid-19 cases are on the rise again in the United States. Even President Biden is infected. But the biggest danger is not the virus—the now-dominant…
